AB Biosciences Competitors and Similar CompaniesClear all
AB Biosciences's competitors and similar companies include PDL BioPharma, AbilityPharma, Ascentage Pharma and Outlook Therapeutics.
 AB Biosciences AB Biosciences is a company that provides antibody-based biologics for biomedical and biopharmaceutical communities. |  PDL BioPharma PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities. |  AbilityPharma AbilityPharma (also known as Ability Pharmaceuticals) is a biopharmaceutical company developing drugs targeting cancer. |  Ascentage Pharma Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies. |  Outlook Therapeutics Outlook Therapeutics (formerly Oncobiologics) is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. | |
Founding Date | Founding Date 2007 | Founding Date 1986 | Founding Date 2009 | Founding Date 2017 | Founding Date 2011 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Concord, US HQ | Locations Incline Village, US HQ | Locations Barcelona, ES HQ Cerdanyola Del Vallès, ES | Locations Suzhou, CN HQ Guangzhou Shi, CN Suzhou Shi, CN Taizhou, CN Rockville, US | Locations Woodbridge Township, US HQ |
Employees | Employees 5 | Employees 10521% increase | Employees 23 | Employees 567 | Employees 1726% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 282.1 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 136.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $54.8m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) ¥574.1m (FY, 2025) | Revenue (est.) $1.4m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $53.6m (FY, 2019) | Cost of goods N/A | Cost of goods ¥48.9m (FY, 2025) | Cost of goods $1.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $1.1m (FY, 2019) | Gross profit N/A | Gross profit ¥546.6m (FY, 2025) | Gross profit $57.2k (FY, 2025) |
Net income | Net income N/A | Net income ($70.7m) (FY, 2019) | Net income N/A | Net income (¥1.2b) (FY, 2025) | Net income ($62.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
PDL BioPharma
HQ
Incline Village, US
Employees
105↑ 21% increase
PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities.
View companyAbilityPharma
HQ
Barcelona, ES
Employees
23
AbilityPharma (also known as Ability Pharmaceuticals) is a biopharmaceutical company developing drugs targeting cancer.
View companyAscentage Pharma
HQ
Suzhou, CN
Employees
567
Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.
View companyOutlook Therapeutics
HQ
Woodbridge Township, US
Employees
17↓ 26% decrease
Outlook Therapeutics (formerly Oncobiologics) is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics.
View company